Medtronic to Showcase Long-Term Evidence and Neuromodulation Therapy Advances at the North American Neuromodulation Society Annual Meeting

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, will be on site at the North American Neuromodulation Society (NANS) 2026 Annual Meeting, January 22-25, at Caesars Palace in Las Vegas. Medtronic will present new long-term clinical data for Inceptiv™ spinal cord stimulation (SCS) and spotlight how sensing-enabled innovation is defining the future of personalized therapy in Neuromodulation.

"We are advancing Neuromodulation by pairing proven therapies with sensing to generate meaningful, real-world data," said Ashwini Sharan, MD, Chief Medical Officer of Neuromodulation at Medtronic. "This approach allows clinicians to better understand therapy response over time and personalize patient care. At NANS 2026, we look forward to sharing how these capabilities are shaping the next chapter of Medtronic Neuromodulation advancement."

A highlight of Medtronic's presence at NANS 2026 will be new two-year closed-loop SCS study data. A separate, independent presentation of real-world Inceptiv™ SCS data complements this work. These findings contribute to the growing body of long-term SCS evidence for evaluating closed-loop approaches.

"Medtronic pioneered the field of Neuromodulation more than 50 years ago, advancing therapies that have changed what's possible for people living with movement disorder and chronic pain," said Paolo Di Vincenzo, President of the Neuromodulation business, part of Medtronic's Neuroscience portfolio. "That legacy continues today through the most comprehensive Neuromodulation portfolio in the industry, and we remain focused on continuous advancement."

Medtronic Neuromodulation leadership will be on site, including Paolo Di Vincenzo, president, Neuromodulation; Ashwini Sharan, MD, Chief Medical Officer of Neuromodulation; Kimberly Thomas-Pollei, PhD, vice president clinical research and medical science, Neuromodulation; and Domenico De Paolis, vice president global strategy, marketing, medical education, and international markets, Neuromodulation.

Featured Medtronic Sessions and Activities

NANS Lunch Symposium "Originator to Innovator: Shaping the Future of Neuromodulation"
Join Paolo DiVincenzo, president, Neuromodulation, and distinguished faculty for a multidisciplinary lunch symposium exploring how deep brain simulation (DBS), SCS, and targeted drug delivery (TDD) work across the continuum of care, when each therapy is most impactful, and how continued innovation is shaping the future of neuromodulation. The session will feature practical insights, real-world perspectives, and patient stories.

• Date: Friday, January 23, 2026
• Time: 11:30 a.m. - 1:00 p.m. PST
• Location: Emperors Level, Augustus I & II
• Presenters:
  • Melissa Murphy, MD, MPH, North Texas Orthopedic and Spine Center, Dallas-Fort Worth, TX
  • Anjum Bux, MD, Bux Pain Management, Denville, KY
  • Krishnan Chakravarthy, MD, PhD, Innovative Pain Treatment Solutions, San Diego, CA
  • Adolfo Rameriz-Zamora, MD, Professor and Chair, Department of Neurology, University of Louisville, Louisville, KY
  • Leonard Oldums (Medtronic patient) - SCS patient
  • Farris Thompson (Medtronic patient) - DBS patient
  • Mary Lemp (Medtronic patient) - TDD patient

NANS Innovation Theatre: "Multi-Waveform Closed-Loop Programming"
Featuring expert perspectives and a live patient demo, discover how multiple waveforms and closed-loop programming can be applied in clinical practice.

• Date: Saturday, January 24, 2026
• Time: 9:30 a.m. - 10:00 a.m. PST
• Location: Exhibit Floor, Julius Ballroom
• Presenters:
  • Melissa Murphy, MD, MPH, North Texas Orthopedic and Spine Center, Dallas-Fort Worth, TX
  • Leonard Oldums (Medtronic patient)

Oral Abstract Presentation: Final 24-Month Outcomes with a Flexible Closed-Loop Spinal Cord Stimulation System

• Session: Plenary IV: Hot Off the Press: Late Breaking Science
• Date: Saturday, January 24, 2026
• Time: 1:25 p.m. - 1:35 p.m. PST
• Location: Octavius Ballroom 4
• Presenters:
  • Vahid Mohabbati, MD, Head of Department Pain Management, Sydney Pain Management Centre, Sydney, New South Wales, Australia

Medtronic Booth (#121)
Early-career physicians are invited to participate in hands-on demonstrations throughout the meeting.

• Friday, January 23 | 9:30 - 10:00 a.m. PST - Kyphon™ balloon kyphoplasty, led by Chris Beuer, MD
• Friday, January 23 | 3:00 - 3:30 p.m. PST - Accurian™ radiofrequency ablation, led by Chris Beuer, MD
• Saturday, January 24 | 3:00 - 3:30 p.m. PST - Spinal Cord Stimulation, led by Samir Sheth, MD

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Naomi Rodiles
Public Relations
+1-612-427-5521

Ingrid Goldberg
Investor Relations
[email protected]